| Date Filed | Type | Description |
| 08/16/2023 |
4
| Atlas Venture Fund X, L.P. (10% Owner) has filed a Form 4 on Disc Medicine, Inc.|
Txns:
| Sold 75,000 shares
@ $52, valued at
$3.9M
Sold 98,000 shares
@ $53, valued at
$5.2M
Sold 2,000 shares
@ $54.8, valued at
$109.6k
Sold 111,069 shares
@ $52.4, valued at
$5.8M
Sold 72,931 shares
@ $52.4, valued at
$3.8M
|
|
| 08/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/14/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 01/13/2023 |
4
| Atlas Venture Fund X, L.P. (10% Owner) has filed a Form 4 on Kymera Therapeutics, Inc.|
Txns:
| Sold 21,683 shares
@ $29.96, valued at
$649.6k
Sold 6,071 shares
@ $29.96, valued at
$181.9k
Sold 77,128 shares
@ $30.29, valued at
$2.3M
Sold 21,592 shares
@ $30.29, valued at
$654k
|
|
| 01/03/2023 |
4
| Atlas Venture Fund X, L.P. (10% Owner) has filed a Form 4 on Disc Medicine, Inc.|
Txns:
| Acquired 1,835,799 shares
@ $0
Acquired 882,224 shares
@ $0 |
|
| 12/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/06/2022 |
SC 13D/A
| Atlas Venture Fund X, L.P. reports a 3% stake in REPLIMUNE GROUP, INC. |
| 11/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/14/2022 |
SC 13D/A
| Atlas Venture Fund X, L.P. reports a 4.4% stake in REPLIMUNE GROUP, INC. |
| 05/05/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/11/2022 |
SC 13D
| Atlas Venture Fund X, L.P. reports a 8.1% stake in IKENA ONCOLOGY, INC. |
| 02/11/2022 |
SC 13G/A
| Atlas Venture Fund X, L.P. reports a 11.2% stake in Kymera Therapeutics, Inc. |
| 02/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 09/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/25/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/16/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/16/2021 |
SC 13G
| Atlas Venture Fund X, L.P. reports a 17.9% stake in Kymera Therapeutics, Inc. |
| 02/16/2021 |
SC 13D
| Atlas Venture Fund X, L.P. reports a 8.9% stake in GEMINI THERAPEUTICS, INC. |
| 02/11/2021 |
3
| Atlas Venture Fund X, L.P. (10% Owner) has filed a Form 3 on Gemini Therapeutics, Inc. /DE |
| 12/17/2020 |
4
| Atlas Venture Fund X, L.P. (10% Owner) has filed a Form 4 on Generation Bio Co.|
Txns:
| Disposed of 1,151,882 shares
@ $0 |
|
| 09/17/2020 |
SC 13D/A
| Atlas Venture Fund X, L.P. reports a 6.3% stake in REPLIMUNE GROUP, INC. |
| 09/17/2020 |
4
| Atlas Venture Fund X, L.P. (10% Owner) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Disposed of 445,339 shares
@ $0 |
|
| 08/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/20/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/14/2020 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
|